Transforming healthcare: Saudi Arabia's vision 2030 healthcare model.

IF 3.3 Q1 HEALTH POLICY & SERVICES Journal of Pharmaceutical Policy and Practice Pub Date : 2025-01-21 eCollection Date: 2025-01-01 DOI:10.1080/20523211.2024.2449051
Amal K Suleiman, Long Chiau Ming
{"title":"Transforming healthcare: Saudi Arabia's vision 2030 healthcare model.","authors":"Amal K Suleiman, Long Chiau Ming","doi":"10.1080/20523211.2024.2449051","DOIUrl":null,"url":null,"abstract":"<p><p>Vision 2030 represents Saudi Arabia's strategic socio-economic plan aimed at promoting economic diversification and enhancing living standards. Launched in April 2016, this vision describes an innovative healthcare plan to improve services and outcomes. The merits and drawbacks of public hospitals' 'Model of Care' are examined in this study. This assessment summarises Vision 2030s healthcare revolution. This study explores the innovative 'Model of Care' and its potential to change Saudi healthcare. Prior to Vision 2030, Saudi Arabia's healthcare system grappled with escalating costs and a heavy reliance on foreign labour, signalling a need for transformative change. Vision 2030s patient-centric framework emphasises individualised treatment, and the National Guidelines Center's role in standardising healthcare processes is examined in this review. In addition, we also explored the new initiative of Electronic Health Records and telemedicine services. Additionally, we addressed the challenges associated with it, such as the imperative to address the digital divide and ensure data security. Vision 2030 in Saudi Arabia brought about a significant transformation in the provision of healthcare. Despite the presence of challenges, such as inadequate infrastructure, insufficient personnel, and resistance to change, this vision offers a robust foundation for effectively tackling these concerns. The implementation of these improvements is expected to enhance the calibre and accessibility of healthcare services. This transitional change ensures healthcare is both innovative and inclusive, particularly in socioeconomically disadvantaged regions. This measure is expected to enhance the general welfare and economic success of the population in Saudi Arabia. The future of healthcare in the Kingdom hinges on the effective implementation of evidence-based therapy, collaborative cooperation, and equitable practices. The healthcare sector possesses significant potential for substantial positive transformation, notwithstanding its continuous nature.</p>","PeriodicalId":16740,"journal":{"name":"Journal of Pharmaceutical Policy and Practice","volume":"18 1","pages":"2449051"},"PeriodicalIF":3.3000,"publicationDate":"2025-01-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11753010/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Pharmaceutical Policy and Practice","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/20523211.2024.2449051","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"HEALTH POLICY & SERVICES","Score":null,"Total":0}
引用次数: 0

Abstract

Vision 2030 represents Saudi Arabia's strategic socio-economic plan aimed at promoting economic diversification and enhancing living standards. Launched in April 2016, this vision describes an innovative healthcare plan to improve services and outcomes. The merits and drawbacks of public hospitals' 'Model of Care' are examined in this study. This assessment summarises Vision 2030s healthcare revolution. This study explores the innovative 'Model of Care' and its potential to change Saudi healthcare. Prior to Vision 2030, Saudi Arabia's healthcare system grappled with escalating costs and a heavy reliance on foreign labour, signalling a need for transformative change. Vision 2030s patient-centric framework emphasises individualised treatment, and the National Guidelines Center's role in standardising healthcare processes is examined in this review. In addition, we also explored the new initiative of Electronic Health Records and telemedicine services. Additionally, we addressed the challenges associated with it, such as the imperative to address the digital divide and ensure data security. Vision 2030 in Saudi Arabia brought about a significant transformation in the provision of healthcare. Despite the presence of challenges, such as inadequate infrastructure, insufficient personnel, and resistance to change, this vision offers a robust foundation for effectively tackling these concerns. The implementation of these improvements is expected to enhance the calibre and accessibility of healthcare services. This transitional change ensures healthcare is both innovative and inclusive, particularly in socioeconomically disadvantaged regions. This measure is expected to enhance the general welfare and economic success of the population in Saudi Arabia. The future of healthcare in the Kingdom hinges on the effective implementation of evidence-based therapy, collaborative cooperation, and equitable practices. The healthcare sector possesses significant potential for substantial positive transformation, notwithstanding its continuous nature.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
求助全文
约1分钟内获得全文 去求助
来源期刊
Journal of Pharmaceutical Policy and Practice
Journal of Pharmaceutical Policy and Practice Health Professions-Pharmacy
CiteScore
4.70
自引率
9.50%
发文量
81
审稿时长
14 weeks
期刊最新文献
Medication-focused telehealth interventions to reduce the hospital readmission rate: a systematic review. The prevalence of thromboembolic events among COVID-19 patients admitted to a single centre intensive care unit (ICU): an epidemiological study from a Malaysian population. Exploring medicine classification and accessibility: a qualitative study. Impact of pharmacist-led medication review among hemodialysis patients: a systematic review. Perceptions, practices, and experiences of asthma patients and community pharmacists on short-acting beta-2 agonists inhaler use: A qualitative study.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1